Literature DB >> 16553773

Hippocampal vulnerability following traumatic brain injury: a potential role for neurotrophin-4/5 in pyramidal cell neuroprotection.

N C Royo1, V Conte, K E Saatman, S Shimizu, C M Belfield, K M Soltesz, J E Davis, S T Fujimoto, T K McIntosh.   

Abstract

Traumatic brain injury (TBI) causes selective hippocampal cell death, which is believed to be associated with cognitive impairment observed both in clinical and experimental settings. Although neurotrophin administration has been tested as a strategy to prevent cell death following TBI, the potential neuroprotective role of neurotrophin-4/5 (NT-4/5) in TBI remains unknown. We hypothesized that NT-4/5 would offer neuroprotection for selectively vulnerable hippocampal neurons following TBI. Measurements of NT-4/5 in rats subjected to lateral fluid percussion (LFP) TBI revealed two-threefold increases in the injured cortex and hippocampus in the acute period (1-3 days) following brain injury. Subsequently, the response of NT-4/5 knockout (NT-4/5(-/-)) mice to controlled-cortical impact TBI was investigated. NT-4/5(-/-) mice were more susceptible to selective pyramidal cell loss in Ahmon's corn (CA) subfields of the hippocampus following TBI, and showed impaired motor recovery when compared with their brain-injured wild-type controls (NT-4/5(wt)). Additionally, we show that acute, prolonged administration of recombinant NT-4/5 (5 microg/kg/day) prevented up to 50% of the hippocampal CA pyramidal cell death following LFP TBI in rats. These results suggest that post-traumatic increases in endogenous NT-4/5 may be part of an adaptive neuroprotective response in the injured brain, and that administration of this neurotrophic factor may be useful as a therapeutic strategy following TBI.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16553773     DOI: 10.1111/j.1460-9568.2006.04642.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  30 in total

1.  Fluorophilia: fluorophore-containing compounds adhere non-specifically to injured neurons.

Authors:  Bridget E Hawkins; Christopher J Frederickson; Douglas S Dewitt; Donald S Prough
Journal:  Brain Res       Date:  2011-11-11       Impact factor: 3.252

Review 2.  Molecular and cellular immune mediators of neuroprotection.

Authors:  Nicolas P Turrin; Serge Rivest
Journal:  Mol Neurobiol       Date:  2006-12       Impact factor: 5.590

3.  Systemic Inflammation during the First Postnatal Month and the Risk of Attention Deficit Hyperactivity Disorder Characteristics among 10 year-old Children Born Extremely Preterm.

Authors:  Elizabeth N Allred; Olaf Dammann; Raina N Fichorova; Stephen R Hooper; Scott J Hunter; Robert M Joseph; Karl Kuban; Alan Leviton; Thomas Michael O'Shea; Megan N Scott
Journal:  J Neuroimmune Pharmacol       Date:  2017-04-12       Impact factor: 4.147

Review 4.  Genetic manipulation of cell death and neuroplasticity pathways in traumatic brain injury.

Authors:  Kathleen M Schoch; Sindhu K Madathil; Kathryn E Saatman
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

5.  Critical role of trkB receptors in reactive axonal sprouting and hyperexcitability after axonal injury.

Authors:  Stephanie Aungst; Pamela M England; Scott M Thompson
Journal:  J Neurophysiol       Date:  2012-11-14       Impact factor: 2.714

6.  Circulating biomarkers in extremely preterm infants associated with ultrasound indicators of brain damage.

Authors:  Alan Leviton; Elizabeth N Allred; Raina N Fichorova; T Michael O'Shea; Lynn A Fordham; Karl K C Kuban; Olaf Dammann
Journal:  Eur J Paediatr Neurol       Date:  2018-01-31       Impact factor: 3.140

7.  Rate of neurodegeneration in the mouse controlled cortical impact model is influenced by impactor tip shape: implications for mechanistic and therapeutic studies.

Authors:  Jennifer M Pleasant; Shaun W Carlson; Haojie Mao; Stephen W Scheff; King H Yang; Kathryn E Saatman
Journal:  J Neurotrauma       Date:  2011-04-21       Impact factor: 5.269

8.  IGF1 neuronal response in the absence of MECP2 is dependent on TRalpha 3.

Authors:  Janaina S de Souza; Cassiano Carromeu; Laila B Torres; Bruno H S Araujo; Fernanda R Cugola; Rui M B Maciel; Alysson R Muotri; Gisele Giannocco
Journal:  Hum Mol Genet       Date:  2017-01-15       Impact factor: 6.150

9.  Long-term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.

Authors:  Melissa J Alldred; Helen M Chao; Sang Han Lee; Judah Beilin; Brian E Powers; Eva Petkova; Barbara J Strupp; Stephen D Ginsberg
Journal:  FASEB J       Date:  2019-06-10       Impact factor: 5.191

10.  VGF (TLQP-62)-induced neurogenesis targets early phase neural progenitor cells in the adult hippocampus and requires glutamate and BDNF signaling.

Authors:  Smita Thakker-Varia; Joseph Behnke; David Doobin; Vidhi Dalal; Keya Thakkar; Farah Khadim; Elizabeth Wilson; Alicia Palmieri; Hanna Antila; Tomi Rantamaki; Janet Alder
Journal:  Stem Cell Res       Date:  2014-03-26       Impact factor: 2.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.